The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial

Cariprazine, a dopamine D3-receptor-preferring partial agonist, blocks phencyclidine-induced impairments of working memory, attention set-shifting, and recognition memory in the mouse

(2012) Ross Zimnisky et al.   PSYCHOPHARMACOLOGY

Poster #16 CARIPRAZINE, A D3/D2 DOPAMINE RECEPTOR PARTIAL AGONIST ANTIPSYCHOTIC, DISPLAYS GREATER D3 RECEPTOR OCCUPANCY IN VIVO COMPARED WITH OTHER ANTIPSYCHOTICS

(2012) Bela Kiss et al.   SCHIZOPHRENIA RESEARCH

Clinical Relevance of Treatments for Acute Bipolar Disorder: Balancing Therapeutic and Adverse Effects

(2011) Shefali Srivastava et al.   CLINICAL THERAPEUTICS

Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents

(2011) István Gyertyán et al.   NEUROCHEMISTRY INTERNATIONAL

Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions?

(2010) T. A. Ketter et al.   ACTA PSYCHIATRICA SCANDINAVICA

Current perspectives on the selective regulation of dopamine D2 and D3 receptors

(2010) Dong Im Cho et al.   ARCHIVES OF PHARMACAL RESEARCH

Antipsychotic Occupancy of Dopamine Receptors in Schizophrenia

(2010) Magdalena Nord et al.   CNS Neuroscience & Therapeutics

Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis

(2010) Jorge M. Tamayo et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile

(2010) B. Kiss et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Efficacy of Antimanic Treatments: Meta-analysis of Randomized, Controlled Trials

(2010) Ayşegül Yildiz et al.   NEUROPSYCHOPHARMACOLOGY

P.2.e.037 The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial

(2009) M. Knesevich et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Residual Symptom Recovery From Major Affective Episodes in Bipolar Disorders and Rapid Episode Relapse/Recurrence

(2008) Lewis L. Judd et al.   ARCHIVES OF GENERAL PSYCHIATRY

Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: II. behavioural characterisation of RG-15

(2008) István Gyertyán et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: I. neurochemical characterisation of RG-15

(2008) Béla Kiss et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY